Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Medication Treatments

News
Individuals in Low-Access Areas Less Likely to Stay in Treatment
06/02/2021
Individuals are up to 50% less likely to stay in treatment for opioid use disorder when they live more than a mile from the nearest provider, according to a study by researchers at Ohio State University’s Wexner Medical Center and Colleges of...
Individuals are up to 50% less likely to stay in treatment for opioid use disorder when they live more than a mile from the nearest provider, according to a study by researchers at Ohio State University’s Wexner Medical Center and Colleges of...
Individuals are up to 50% less...
06/02/2021
Addiction Professional
NIDA Leaders: Extended-Release OUD Medication Formulations Could Improve Adherence
05/13/2021
Following a strategy that has proven effective for improving adherence to other medications, leaders from the National Institute on Drug Abuse say the key to improving retention rates among patients receiving medication-assisted treatment for...
Following a strategy that has proven effective for improving adherence to other medications, leaders from the National Institute on Drug Abuse say the key to improving retention rates among patients receiving medication-assisted treatment for...
Following a strategy that has...
05/13/2021
Addiction Professional
FDA Approves Higher-Dose Naloxone Product
05/11/2021
The U.S. Food and Drug Administration has approved a higher dose naloxone nasal spray product. The new product, Kloxxado, delivers 8 mg of naloxone into the nasal cavity, which is double the 4 mg delivered in Narcan. A 2 mg formulation of...
The U.S. Food and Drug Administration has approved a higher dose naloxone nasal spray product. The new product, Kloxxado, delivers 8 mg of naloxone into the nasal cavity, which is double the 4 mg delivered in Narcan. A 2 mg formulation of...
The U.S. Food and Drug...
05/11/2021
Addiction Professional
Early Study Findings Show Low-Dose Naltrexone Helps Chronic Pain Patients
05/04/2021
Preliminary data from researchers at the University of Pittsburgh Medical Center showed that naltrexone, a medication used to treat opioid and alcohol use disorder, reduced both pain and disability in chronic pain patients when administered...
Preliminary data from researchers at the University of Pittsburgh Medical Center showed that naltrexone, a medication used to treat opioid and alcohol use disorder, reduced both pain and disability in chronic pain patients when administered...
Preliminary data from...
05/04/2021
Addiction Professional
1 in 5 Pharmacies Won`t Dispense Buprenorphine
1 in 5 Pharmacies Won`t Dispense Buprenorphine
04/30/2021
One barrier to expanding access to medication-assisted treatment was cleared this week when the Department of Health and Human Services announced plans to exempt most clinicians from training requirements for prescribing buprenorphine.
One barrier to expanding access to medication-assisted treatment was cleared this week when the Department of Health and Human Services announced plans to exempt most clinicians from training requirements for prescribing buprenorphine.
One barrier to expanding access...
04/30/2021
Addiction Professional
New HHS Guidelines Exempt Nearly All Prescribers from X-Waiver Requirement
New HHS Guidelines Exempt Nearly All Prescribers from X-Waiver Requirement
04/27/2021
The Department of Health and Human Services announced on Tuesday it is releasing a new version of its Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder that will allow nearly all prescribers to treat...
The Department of Health and Human Services announced on Tuesday it is releasing a new version of its Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder that will allow nearly all prescribers to treat...
The Department of Health and...
04/27/2021
Addiction Professional
Pandemic Linked with Decrease in Patients Receiving Buprenorphine for OUD
Pandemic Linked with Decrease in Patients Receiving Buprenorphine for OUD
04/20/2021
A study by researchers at Princeton University has identified a series of specific ways in which the COVID-19 pandemic has been associated with an increase in opioid overdose deaths. Their findings were published this month by JAMA Network...
A study by researchers at Princeton University has identified a series of specific ways in which the COVID-19 pandemic has been associated with an increase in opioid overdose deaths. Their findings were published this month by JAMA Network...
A study by researchers at...
04/20/2021
Addiction Professional
MAT Access for OUD Lower for Patients Involved with Criminal Justice System
MAT Access for OUD Lower for Patients Involved with Criminal Justice System
04/15/2021
A new study from researchers at the University of Pennsylvania has found that Medicaid expansion has been associated with “substantial improvements” in access to medications for the treatment of opioid use disorder for individuals referred to...
A new study from researchers at the University of Pennsylvania has found that Medicaid expansion has been associated with “substantial improvements” in access to medications for the treatment of opioid use disorder for individuals referred to...
A new study from researchers at...
04/15/2021
Addiction Professional
CDC Translating Knowledge into Action as Addiction Crisis Evolves
CDC Translating Knowledge into Action as Addiction Crisis Evolves
04/07/2021
The addiction crisis of today is not the same as those that preceded it even 2 years ago, and while there are reasons for concern, CDC director Rochelle Walensky, MD, MPH, told Rx Drug Abuse & Heroin Summit attendees in a session presented...
The addiction crisis of today is not the same as those that preceded it even 2 years ago, and while there are reasons for concern, CDC director Rochelle Walensky, MD, MPH, told Rx Drug Abuse & Heroin Summit attendees in a session presented...
The addiction crisis of today is...
04/07/2021
Addiction Professional
After 18 Months, CODAC Partnership with Mass. Sheriff’s Department Getting Results
After 18 Months, CODAC Partnership with Mass. Sheriff’s Department Getting Results
03/19/2021
A collaboration between the Hampden County (Massachusetts) Sheriff’s Department and CODAC Behavioral Healthcare to provide medication-assisted treatment to incarcerated individuals with substance use disorders is making headway 18 months...
A collaboration between the Hampden County (Massachusetts) Sheriff’s Department and CODAC Behavioral Healthcare to provide medication-assisted treatment to incarcerated individuals with substance use disorders is making headway 18 months...
A collaboration between the...
03/19/2021
Addiction Professional

Advertisement

Advertisement

Browse Our Other Brands

Psych NP Institute

 

Psych Congress Network

 

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement